Marker Therapeutics, Inc. Profile Avatar - Palmy Investing

Marker Therapeutics, Inc.

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indic…

Biotechnology
US, Houston [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Marker Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Marker Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Marker Therapeutics, Inc..

End of MRKR's Analysis
CIK: 1094038 CUSIP: 57055L107 ISIN: US57055L2060 LEI: - UEI: -
Secondary Listings
MRKR has no secondary listings inside our databases.